haloperidol has been researched along with Apraxias in 2 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Apraxias: A group of cognitive disorders characterized by the inability to perform previously learned skills that cannot be attributed to deficits of motor or sensory function. The two major subtypes of this condition are ideomotor (see APRAXIA, IDEOMOTOR) and ideational apraxia, which refers to loss of the ability to mentally formulate the processes involved with performing an action. For example, dressing apraxia may result from an inability to mentally formulate the act of placing clothes on the body. Apraxias are generally associated with lesions of the dominant PARIETAL LOBE and supramarginal gyrus. (From Adams et al., Principles of Neurology, 6th ed, pp56-7)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Reported is a 19-year-old manic-depressive patient who developed persistent dysarthria with coexisting apraxia while on a combination of high dose haloperidol and lithium carbonate." | 7.66 | Persistent dysarthria with apraxia associated with a combination of lithium carbonate and haloperidol. ( Bond, WS; Carvalho, M; Foulks, EF, 1982) |
| "Reported is a 19-year-old manic-depressive patient who developed persistent dysarthria with coexisting apraxia while on a combination of high dose haloperidol and lithium carbonate." | 3.66 | Persistent dysarthria with apraxia associated with a combination of lithium carbonate and haloperidol. ( Bond, WS; Carvalho, M; Foulks, EF, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bond, WS | 1 |
| Carvalho, M | 1 |
| Foulks, EF | 1 |
| Niss, AI | 1 |
| Trubkovich, MIa | 1 |
2 other studies available for haloperidol and Apraxias
| Article | Year |
|---|---|
Persistent dysarthria with apraxia associated with a combination of lithium carbonate and haloperidol.
Topics: Adult; Apraxias; Bipolar Disorder; Drug Therapy, Combination; Dysarthria; Haloperidol; Humans; Lithi | 1982 |
[Various rarely encountered adverse effects and complications of psychopharmacotherapy].
Topics: Adult; Agnosia; Amitriptyline; Apraxias; Brain Diseases; Cerebral Cortex; Haloperidol; Humans; Male; | 1985 |